Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Mangner

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 15, 2022
Optimized patient selection in high-risk protected percutaneous coronary interventionJürgen Leick, Nikos Werner, Norman Mangner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 22, 2021
Remote proctoring for high-risk coronary interventions with mechanical circulatory support during COVID-19 pandemic and beyondFelix J Woitek, Stephan Haussig, Johannes Mierke, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 14, 2023
From escalation to weaning strategies: how to integrate the ECMELLA conceptBenedikt Schrage, Alexander Bernhardt, Evgenij Potapov, et al.
Plos One|May 19, 2012
Regular exercise or changing diet does not influence aortic valve disease progression in LDLR deficient miceFlorian Schlotter, Yasuharu Matsumoto, Norman Mangner, et al.
Circulation|February 4, 2010
Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient miceYasuharu Matsumoto, Volker Adams, Saskia Jacob, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 29, 2026
Optimizing protected PCI strategies in the setting of chronic kidney disease and advanced coronary artery disease: a clinical case-based discussionMario Iannaccone, Jerzy Sacha, María Monteagudo-Vela, et al.
CJC Open|October 27, 2020
Paraneoplastic Syndrome and SARS-CoV-2-Incremental Effect of 2 Thrombogenic Conditions?Norman Mangner, Krunoslav Sveric, Johannes C Gerber, et al.
Journal of Visualized Experiments : Jove|March 8, 2012
The WATCHMAN left atrial appendage closure device for atrial fibrillationSven Möbius-Winkler, Marcus Sandri, Norman Mangner, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 29, 2026
Protected complex high-risk indicated percutaneous coronary intervention in severe left ventricular dysfunction: an illustrative case highlighting patient selection, procedural planning, execution, and device managementSaad M Ezad, Mohammad Alkhalil, María Monteagudo-Vela, et al.
Muscle & Nerve|March 21, 2012
Muscle function and running activity in mouse models of hereditary muscle dystrophy: impact of double knockout for dystrophin and the transcription factor MyoDNorman Mangner, Volker Adams, Marcus Sandri, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 15, 2022
Optimized patient selection in high-risk protected percutaneous coronary interventionJürgen Leick, Nikos Werner, Norman Mangner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 22, 2021
Remote proctoring for high-risk coronary interventions with mechanical circulatory support during COVID-19 pandemic and beyondFelix J Woitek, Stephan Haussig, Johannes Mierke, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 14, 2023
From escalation to weaning strategies: how to integrate the ECMELLA conceptBenedikt Schrage, Alexander Bernhardt, Evgenij Potapov, et al.
Plos One|May 19, 2012
Regular exercise or changing diet does not influence aortic valve disease progression in LDLR deficient miceFlorian Schlotter, Yasuharu Matsumoto, Norman Mangner, et al.
Circulation|February 4, 2010
Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient miceYasuharu Matsumoto, Volker Adams, Saskia Jacob, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 29, 2026
Optimizing protected PCI strategies in the setting of chronic kidney disease and advanced coronary artery disease: a clinical case-based discussionMario Iannaccone, Jerzy Sacha, María Monteagudo-Vela, et al.
CJC Open|October 27, 2020
Paraneoplastic Syndrome and SARS-CoV-2-Incremental Effect of 2 Thrombogenic Conditions?Norman Mangner, Krunoslav Sveric, Johannes C Gerber, et al.
Journal of Visualized Experiments : Jove|March 8, 2012
The WATCHMAN left atrial appendage closure device for atrial fibrillationSven Möbius-Winkler, Marcus Sandri, Norman Mangner, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 29, 2026
Protected complex high-risk indicated percutaneous coronary intervention in severe left ventricular dysfunction: an illustrative case highlighting patient selection, procedural planning, execution, and device managementSaad M Ezad, Mohammad Alkhalil, María Monteagudo-Vela, et al.
Muscle & Nerve|March 21, 2012
Muscle function and running activity in mouse models of hereditary muscle dystrophy: impact of double knockout for dystrophin and the transcription factor MyoDNorman Mangner, Volker Adams, Marcus Sandri, et al.
Pageof 18